Investment: TRAINM

Specialists state that up to 1 in 3 Europeans will suffer at least once in their lifetime from a disease affecting the neurological system. This leads to great human suffering and restricts the independence of those suffering from these diseases as a result of disability and the need for care. The financial and non-financial burden on those affected, their social environment and on health care systems is enormous.

Investment specifications

  • Company's inception year: 2016

  • KOIS investment year: 2016

  • Target population: children and adults suffering from neurological and orthopedic disabilities

  • Geographies: Belgium


Nilofar Niazi and Edward Schiettecatte gave up their career in the US to start TRAINM, when they found out that the chances that their son, affected by a cerebral palsy, would ever walk, talk or see were close to zero.

TRAINM is an outpatient neuro-rehabilitation clinic for children and adults with a broad range of neurological and orthopaedic disabilities, such as stroke, multiple sclerosis and Parkinson. Therapy is based on neuroplasticity, reducing neurological deficits from injuries to the brain and spinal cord. Patients receive on average 1,000 movements per session, 20 times more than conventional physical therapy.

Therapies include personalised high intensity therapies, coupled with non-invasive brain stimulation, neuro-technology, virtual reality, neuro gaming, artificial intelligence and robotics. Patients who do not have the financial means to receive outpatient treatment at TRAINM may be eligible to receive assistance from the TRAINM Foundation.

In 2016, KOIS invested in TRAINM because of its potential to offer life-changing therapy to people who otherwise would not have a viable chance of recovery. Initiatives like TRAINM bridge the gap between discoveries made in research laboratories and the patients’ needs.

TRAINM's impact in 2019

  • 250+ patients

  • 9000 + robotics sessions

  • 1000+ neuro-modulation sessions

For more info on TRAINM; visit https://trainm.com/

Sources: European Brain Council, Institut de la Moëlle Epinière; EAN, Amsterdam 2017, Neurological diseases on the rise: European collaboration in research essential; De Tijd, 7 november 2017

Sign up for our newsletter
  • KOIS LinkedIn
  • KOIS Twitter
Our sectors
About us
Our countries
Our work
Our team
Join us
Contact us
KOIS Brussels
Rue de Livourne 41
1050 Brussels
+32 2 534 36 76
KOIS Mumbai
Anand 105, 6th Floor Pali
Hill, Ambedkar Road
Bandra West, Mumbai 50
+91 22 4924 5771-3
KOIS London
Impact Hub King's Cross
34b York Way
London, N1 9AB
KOIS Paris
57 rue des Francs Bourgeois
75004 Paris

© 2020 KOIS